{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:57:32Z","timestamp":1776185852446,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1186\/s12918-018-0546-1","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T15:55:06Z","timestamp":1542902106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["In silico drug combination discovery for personalized cancer therapy"],"prefix":"10.1186","volume":"12","author":[{"given":"Minji","family":"Jeon","sequence":"first","affiliation":[]},{"given":"Sunkyu","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Sungjoon","family":"Park","sequence":"additional","affiliation":[]},{"given":"Heewon","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Jaewoo","family":"Kang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"issue":"3","key":"546_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical r&d efficiency. Nat Rev Drug Discov. 2012; 11(3):191\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"546_CR2","unstructured":"Clinical Development Success Rates 2006-2015. https:\/\/www.bio.org\/sites\/default\/files\/ClinicalDevelopmentSuccessRates2006-2015-BIO,Biomedtracker,Amplion2016.pdf . Accessed 30 Oct 2017."},{"key":"546_CR3","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1038\/srep07160","volume":"4","author":"H Huang","year":"2014","unstructured":"Huang H, Zhang P, Qu XA, Sanseau P, Yang L. Systematic prediction of drug combinations based on clinical side-effects. Sci Rep. 2014; 4:7160.","journal-title":"Sci Rep"},{"issue":"7","key":"546_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nbt.2284","volume":"30","author":"B Al-Lazikani","year":"2012","unstructured":"Al-Lazikani B, Banerji U, Workman P. Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol. 2012; 30(7):679\u201392.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"546_CR5","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.149","volume":"3","author":"J Foucquier","year":"2015","unstructured":"Foucquier J, Guedj M. Analysis of drug combinations: current methodological landscape. Pharmacol Res perspect. 2015; 3(3):e00149.","journal-title":"Pharmacol Res perspect"},{"issue":"11","key":"546_CR6","doi-asserted-by":"publisher","first-page":"14124","DOI":"10.1371\/journal.pone.0014124","volume":"5","author":"J Meng","year":"2010","unstructured":"Meng J, Dai B, Fang B, Bekele BN, Bornmann WG, Sun D, Peng Z, Herbst RS, Papadimitrakopoulou V, Minna JD, et al. Combination treatment with mek and akt inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo. PloS ONE. 2010; 5(11):14124.","journal-title":"PloS ONE"},{"issue":"12","key":"546_CR7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nbt.3052","volume":"32","author":"M Bansal","year":"2014","unstructured":"Bansal M, Yang J, Karan C, Menden MP, Costello JC, Tang H, Xiao G, Li Y, Allen J, Zhong R, et al. A community computational challenge to predict the activity of pairs of compounds. Nat Biotechnol. 2014; 32(12):1213\u201322.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"546_CR8","doi-asserted-by":"publisher","first-page":"1005308","DOI":"10.1371\/journal.pcbi.1005308","volume":"13","author":"KM Gayvert","year":"2017","unstructured":"Gayvert KM, Aly O, Platt J, Bosenberg MW, Stern DF, Elemento O. A computational approach for identifying synergistic drug combinations. PLoS Comput Biol. 2017; 13(1):1005308.","journal-title":"PLoS Comput Biol"},{"key":"546_CR9","volume-title":"Biocomputing 2012","author":"R Pal","year":"2012","unstructured":"Pal R, Berlow N. A kinase inhibition map approach for tumor sensitivity prediction and combination therapy design for targeted drugs. In: Biocomputing 2012. Singapore: World Scientific Publishing Co.: 2012. p. 351\u201362."},{"issue":"4","key":"546_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12859-017-1523-1","volume":"18","author":"K Matlock","year":"2017","unstructured":"Matlock K, Berlow N, Keller C, Pal R. Combination therapy design for maximizing sensitivity and minimizing toxicity. BMC Bioinformatics. 2017; 18(4):116.","journal-title":"BMC Bioinformatics"},{"key":"546_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1752-0509-4-S2-S7","volume":"4 Suppl 2","author":"Z Wu","year":"2010","unstructured":"Wu Z, Zhao XM, Chen L. A systems biology approach to identify effective cocktail drugs. BMC Syst Biol. 2010; 4 Suppl 2:7.","journal-title":"BMC Syst Biol"},{"issue":"2","key":"546_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1039\/C5MB00599J","volume":"12","author":"D Chen","year":"2016","unstructured":"Chen D, Zhang H, Lu P, Liu X, Cao H. Synergy evaluation by a pathway-pathway interaction network: a new way to predict drug combination. Mol Biosyst. 2016; 12(2):614\u201323.","journal-title":"Mol Biosyst"},{"issue":"12","key":"546_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/bioinformatics\/btu278","volume":"30","author":"L Huang","year":"2014","unstructured":"Huang L, Li F, Sheng J, Xia X, Ma J, Zhan M, Wong ST. Drugcomboranker: drug combination discovery based on target network analysis. Bioinformatics. 2014; 30(12):228\u201336.","journal-title":"Bioinformatics"},{"issue":"18","key":"546_CR14","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli GY, Fornari C, Wang D, Mollard S, Bramhall JL, Richards FM, Jodrell DI. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics. 2016; 32(18):2866\u20138.","journal-title":"Bioinformatics"},{"issue":"6","key":"546_CR15","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","volume":"15","author":"J O\u2019Neil","year":"2016","unstructured":"O\u2019Neil J, Benita Y, Feldman I, Chenard M, Roberts B, Liu Y, Li J, Kral A, Lejnine S, Loboda A, et al. An unbiased oncology compound screen to identify novel combination strategies. Mol Cancer Ther. 2016; 15(6):1155\u201362.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"546_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Gon\u00e7alves E, Barthorpe S, Lightfoot H, et al. A landscape of pharmacogenomic interactions in cancer. Cell. 2016; 166(3):740\u201354.","journal-title":"Cell"},{"key":"546_CR17","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. AACR. 2012."},{"issue":"D1","key":"546_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2013","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, et al. Drugbank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2013; 42(D1):1091\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"546_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2012","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et al. Genomics of drug sensitivity in cancer (gdsc): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012; 41(D1):955\u201361.","journal-title":"Nucleic Acids Res"},{"key":"546_CR20","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1038\/srep05193","volume":"4","author":"B Yadav","year":"2014","unstructured":"Yadav B, Pemovska T, Szwajda A, Kulesskiy E, Kontro M, Karjalainen R, Majumder MM, Malani D, Murum\u00e4gi A, Knowles J, et al. Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies. Sci Rep. 2014; 4:5193.","journal-title":"Sci Rep"},{"issue":"D1","key":"546_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/nar\/gkv1108","volume":"44","author":"J Guo","year":"2016","unstructured":"Guo J, Liu H, Zheng J. Synlethdb: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets. Nucleic Acids Res. 2016; 44(D1):1011\u20137.","journal-title":"Nucleic Acids Res"},{"key":"546_CR22","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V, Vanderplas J, Passos A, Cournapeau D, Brucher M, Perrot M, Duchesnay E. Scikit-learn: Machine learning in Python. J Mach Learn Res. 2011; 12:2825\u201330.","journal-title":"J Mach Learn Res"},{"issue":"1","key":"546_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10994-006-6226-1","volume":"63","author":"P Geurts","year":"2006","unstructured":"Geurts P, Ernst D, Wehenkel L. Extremely randomized trees. Mach Learn. 2006; 63(1):3\u201342.","journal-title":"Mach Learn"},{"issue":"2","key":"546_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1158\/0008-5472.CAN-08-2088","volume":"69","author":"RD Meng","year":"2009","unstructured":"Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, Schwartz GK. \u03b3-secretase inhibitors abrogate oxaliplatin-induced activation of the notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res. 2009; 69(2):573\u201382.","journal-title":"Cancer Res"},{"issue":"4","key":"546_CR25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jcb.22451","volume":"109","author":"Z Wang","year":"2010","unstructured":"Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH. Down-regulation of notch-1 and jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of akt, mtor, and nf- \u03bab signaling pathways. J Cell Biochem. 2010; 109(4):726\u201336.","journal-title":"J Cell Biochem"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-018-0546-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12918-018-0546-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-018-0546-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T17:39:43Z","timestamp":1720805983000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-018-0546-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":25,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1186\/s12918-018-0546-1","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"19 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"16"}}